MedTrace Logo

Bioaerosol Sampling Device (BSD) Clinical Study

NCT06047067 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 330

Last updated 2023-09-21

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about the bioaerosol sampling device (BSD) and how it can sample patient bioaerosols (breath) and patient's nares for the detection of COVID-19 viral particles in patients seeking to be tested for COVID-19.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Robert Azurin, MD · JPRA Enterprises, LLC

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-10
Primary Completion
2024-05-19
Completion
2024-05-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06047067 on ClinicalTrials.gov